Health in Uganda 1,224 indicators covering health for Uganda. IndicatorLatest Year10-yr change Rank Treatment success rate for patients treated for MDR-TB 89.0% 2022 up 11.2% 25th New leprosy case detection rate per 1 000 000 population 4.92 2024 down 30.5% 58th Treatment success rate: HIV-positive TB cases 90 2023 up 23.3% 22nd Prevalence of wasting, weight for height 3.2% 2022 down 23.8% 62nd Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) i 82.0% 2025 — 110th International Health Regulations core capacity scores, SPAR version, 2 60 2025 — 64th Prevalence of underweight, weight for age 9.7% 2022 down 18.5% 49th Leprosy registered prevalence rate per 1 000 000 population 5.68 2024 down 38.9% 64th Leprosy - Number of new leprosy cases among children 28 2024 up 64.7% 24th Leprosy - Number of cases registered for treatment 284 2024 down 21.3% 31st New leprosy child case detection rate (less than 15 years of age) per 1.29 2024 up 35.4% 43rd Children (0-14) living with HIV 71,000 2024 down 40.8% 3rd Ipv1 number unvaccinated 64,962 2023 down 91.7% 45th Children living with hiv 71,000 2024 down 40.8% 3rd Contraceptive prevalence, any method 43.0% 2022 up 43.3% 79th Children (ages 0-14) newly infected with HIV 4,700 2024 down 60.8% 5th Number of reported cases of poliomyelitis by wild poliovirus 0 2023 — 3rd Number of children newly infected with hiv 4,700 2024 down 60.8% 5th Share of children under fifteen years old with hiv 4,733 2024 down 60.9% 5th Number of female leprosy new cases 141 2024 up 1.4% 22nd Estimated number of malaria deaths 16,204 2024 down 8.7% 9th Estimated number of malaria cases 13.22 million 2024 up 24.3% 3rd National smoking ban: NUMBER OF PLACES SMOKE-FREE 8 2022 up 60.0% 1st Contraceptive prevalence, any modern method 38.0% 2022 up 46.2% 72nd Number of prevalent tuberculosis cases 60,000 2014 down 27.7% 27th Estimated malaria incidence 264.23 2024 down 9.5% 14th Estimated malaria mortality rate 32.4 2024 down 33.6% 27th Number of new G2D leprosy cases 51 2024 down 33.8% 22nd Leprosy - New leprosy cases with G2D rate per 1 000 000 population 1.02 2024 down 48.6% 46th Reported rate of new cervical cancer cases 36.14 2017 down 42.4% 1st Inflation-adjusted prices for most sold brand of cigarettes: Prices in 3.85 2022 up 21.1% 133rd Taxes as a % of price: total tax 29.8% 2022 down 15.6% 159th Taxes as a % of price: value added tax 7.8% 2022 down 49.2% 148th Taxes as a % of price: ad valorem excise 0.0% 2022 — 106th Taxes as a % of price: specific excise 22.0% 2022 up 10.0% 98th Taxes as a % of price: import duties 0.0% 2022 — 38th Taxes as a % of price: other taxes 0.0% 2022 — 57th Vitamin A supplementation coverage rate 38.0% 2023 down 41.5% 37th Inflation-adjusted prices for most sold brand of cigarettes: Price in 5,000 2022 up 34.5% 9th Estimated number of children needing antiretroviral therapy based on W 71,000 2025 down 45.4% 4th Prevalence of severe wasting, weight for height 1.0% 2022 up 233.3% 43rd Physical activity policies for activie societies 20 2023 up 100.0% 2nd Physical activity policies focused on active systems 20 2023 unchanged 5th Midwifery personnel 35,100 2024 up 401.4% 9th Number of deaths from malaria who 16,204 2024 down 8.7% 9th Death rate from malaria 32.4 2024 down 33.6% 27th Incidence of malaria 264.23 2024 down 9.5% 14th Share of one year olds who received the final dose of pneumococcal vac 91 2024 up 51.7% 52nd Diphtheria tetanus pertussis vaccine vs pneumococcal vaccine coverage 91 2024 up 51.7% 52nd Estimated antiretroviral therapy coverage among children 66 2025 up 40.4% 19th Death rate from poisonings 1.1 2021 unchanged 45th Rotavirus number unvaccinated 227,365 2023 down 75.5% 24th Prevalence of stunting, height for age 24.4% 2022 down 27.6% 36th Affordability - percentage of GDP per capita required to purchase 2000 12.76 2022 up 21.5% 27th Malaria cases reported 11.18 million 2024 up 207.9% 4th Deaths and missing persons due to natural disasters 2.65 2022 up 579.5% 45th Mean systolic blood pressure 129.9 2009 up 1.9% 38th Mean fasting blood glucose (mmol/l) 4.8 2009 unchanged 176th Number of pregnant women living with HIV who received antiretrovirals 75,634 2025 down 25.3% 3rd Hiv expenditure 0 2022 — 101st ← Previous Page 15 of 21 Next →